(最終更新日:2022-09-09 10:03:25)
  タニオカ ヒロアキ   Hiroaki Tanioka
  谷岡 洋亮
   所属   川崎医科大学  医学部 臨床医学 臨床腫瘍学
   職種   特任講師
■ 学術雑誌
1. 2022/05 原著 Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed study  Link
2. 2022/05 原著 Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen  Link
3. 2021/11 原著 Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer  Link
4. 2021/05/12 原著 Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases 
5. 2021/05 原著 Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations  Link
全件表示(29件)
■ 学会発表
1. 2022/03/04 REVIVE試験:ニボルマブの奏効別の救済化学療法の治療効果について (口頭発表,一般) 
2. 2022/02/17 A Phase III trial of sequential versus combination in metastatic colorectal cancer: C-Cubed study (口頭発表,一般) 
3. 2022/02/17 Fluctuating PD-1 ratio in blood may predict clinical outcome of upper gastrointestinal cancer patients under ICI therapy (ポスター,一般) 
4. 2022/02/17 RAS/RAF/Microsatellite statusに間葉型を加えた新しいサブタイプによる大腸癌のPrecision Medicine (ポスター,一般) 
5. 2022/02/17 REVIVE study: An Observational Study in Chemotherapy (CTx) after Nivolumab (NIVO) for Advanced Gastric Cancer (AGC) (口頭発表,一般) 
全件表示(66件)